Glass Pipes and Bongs

"In this systematic review, cannabinoid-based therapies showed lower neuropsychiatric symptom and agitation scores than placebo in patients with moderate-to-severe AD."The post Cannabis-Based Therapies Improve Alzheimer’s-Related Agitation  appeared first on NORML. Go to the article

The most significant reductions occurred in participants who consumed higher doses of CBD (up to 600 mg/day).The post Review: CBD Dosing Reduces Blood Pressure in a Dose-Dependent Manner appeared first on NORML. Go to the article

Forty-two percent of respondents said that they substituted cannabis for prescription anxiolytics or antidepressants.The post Survey: Women Frequently Substitute Cannabis for Prescription Drugs to Manage Anxiety, Depression appeared first on NORML. Go to the article

Investigators identified "meaningful benefits" in patients' sleep quality, pain, and nocturnal urinary frequency following cannabis treatment.The post Study: Cannabis Treatment Provides “Meaningful Benefits” for Patients With Parkinson’s appeared first on NORML. Go to the article

Over 95 percent of the study's participants ceased their use of opioids by the conclusion of the study.The post Study: Cannabis Inhalation Associated With Long-Term Pain Relief, Opioid-Sparing Effects in Patients With Treatment-Resistant Lower Back Pain appeared first on NORML. Go to the article

State-licensed retailers will begin selling cannabis products to those age 21 or older on July 1, 2027.The post Virginia: Provisions Regulating Adult-Use Cannabis Sales Codified into Law appeared first on NORML. Go to the article